What is newborn screening, in plain words
Heel-prick blood, a federal panel, and what state-by-state coverage actually looks like.
Newborn screening is a small heel-prick blood draw, usually done in the first two days of life. The sample goes to a state public health lab. Results come back within days to a couple of weeks. The purpose is narrow. The lab is looking for a fixed list of conditions where catching something before symptoms changes the outcome.
Most parents do not see the test happen. The newborn nursery handles it. The result lands quietly back in the chart. For the small share of babies whose screen is positive, the next step is a confirmatory workup with a specialist, often within days of the screen.
The federal panel and the state map
At the federal level, the Recommended Uniform Screening Panel, the RUSP, lists conditions the federal government recommends every state screen for. The RUSP is a recommendation, not a mandate. Each state decides what it actually screens for. Most states cover the full RUSP. Some add conditions on top. Some lag, especially for newer additions.
The RUSP itself is updated by an evidence review process. Until April 2025, an advisory committee called ACHDNC handled that review. ACHDNC was terminated in April 2025. Updates to the panel still flow through the Health Resources and Services Administration, but the lay-led advisory body is gone. That is a fact, not an editorial.
What the panel covers, in categories
The current RUSP groups conditions into a few buckets. Amino acid disorders include phenylketonuria and maple syrup urine disease. Fatty acid oxidation disorders include MCAD deficiency. Organic acid disorders include propionic acidemia and methylmalonic acidemia. Endocrine disorders include congenital hypothyroidism and congenital adrenal hyperplasia. Hemoglobin disorders include sickle cell disease. Other conditions include cystic fibrosis, severe combined immunodeficiency, spinal muscular atrophy, and a growing set of lysosomal storage disorders that some states cover and others do not.
For most of these, the screen does not give a diagnosis. It gives a flag. The diagnosis comes from confirmatory testing under a specialist. Two things to know about that. First, time matters more than for most pediatric workups, because the conditions on the panel respond to early treatment. Second, the specialist who handles the workup is usually a metabolic geneticist, not a general pediatrician, and not every region has one nearby.
The panel's edges
Newborn screening covers the conditions on the RUSP and a small number of state additions. It catches most cases of those conditions, though not every variant. Ehlers-Danlos and most genetic syndromes that present later in life sit outside its scope. A negative screen is good news on a narrow set of questions; it is one data point about a specific list, not a comprehensive rare-disease screen.
For families whose child has a condition outside the panel, the diagnostic odyssey is its own subject and lives elsewhere on this site. The Zebra Reports network surface is built for that.
What to know if your baby screens positive
A positive screen is most often a false alarm. It means the lab measurement crossed a cutoff. The clinical team will want a confirmatory test quickly. Ask three questions. First, what is the specific condition the screen flagged. Second, what is the confirmatory test and when will the result land. Third, who is the specialist running the confirmation and how do you reach them directly. Write the answers down. Decisions land in the first 48 hours.